SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-23-039413
Filing Date
2023-08-14
Accepted
2023-08-14 08:00:22
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 ny20010068x1_424b5.htm 424B5 941493
2 logo_ocuphirex1.jpg GRAPHIC 53570
3 logo_ocuphirex2.jpg GRAPHIC 75522
4 ny20010068x1_chart1.jpg GRAPHIC 195245
  Complete submission text file 0001140361-23-039413.txt   1388890
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252715 | Film No.: 231166390
SIC: 2834 Pharmaceutical Preparations